Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
Gorodetska I, Offermann A, Püschel J, Lukiyanchuk V, Gaete D, Kurzyukova A, Freytag V, Haider MT, Fjeldbo CS, Di Gaetano S, Schwarz FM, Patil S, Borkowetz A, Erb HHH, Baniahmad A, Mircetic J, Lyng H, Löck S, Linge A, Lange T, Knopf F, Wielockx B, Krause M, Perner S, Dubrovska A. Gorodetska I, et al. Among authors: offermann a. Theranostics. 2024 Jan 1;14(2):714-737. doi: 10.7150/thno.88057. eCollection 2024. Theranostics. 2024. PMID: 38169509 Free PMC article.
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy.
Klusa D, Lohaus F, Franken A, Baumbach M, Cojoc M, Dowling P, Linge A, Offermann A, Löck S, Hušman D, Rivandi M, Polzer B, Freytag V, Lange T, Neubauer H, Kücken M, Perner S, Hölscher T, Dubrovska A, Krause M, Kurth I, Baumann M, Peitzsch C. Klusa D, et al. Among authors: offermann a. Int J Cancer. 2023 Jun 15;152(12):2639-2654. doi: 10.1002/ijc.34457. Epub 2023 Mar 13. Int J Cancer. 2023. PMID: 36733230
The activation of OR51E1 causes growth suppression of human prostate cancer cells.
Maßberg D, Jovancevic N, Offermann A, Simon A, Baniahmad A, Perner S, Pungsrinont T, Luko K, Philippou S, Ubrig B, Heiland M, Weber L, Altmüller J, Becker C, Gisselmann G, Gelis L, Hatt H. Maßberg D, et al. Among authors: offermann a. Oncotarget. 2016 Jul 26;7(30):48231-48249. doi: 10.18632/oncotarget.10197. Oncotarget. 2016. PMID: 27374083 Free PMC article.
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer.
Besler K, Węglarz A, Keller L, von Amsberg G, Bednarz-Knoll N, Offermann A, Stoupiec S, Eltze E, Semjonow A, Boettcher L, Schneegans S, Perner S, Hauch S, Todenhöfer T, Peine S, Pantel K, Wikman H, Werner S. Besler K, et al. Among authors: offermann a. Clin Chem. 2022 Jul 3;68(7):973-983. doi: 10.1093/clinchem/hvac073. Clin Chem. 2022. PMID: 35652463
Experimental in vitro, ex vivo and in vivo models in prostate cancer research.
Sailer V, von Amsberg G, Duensing S, Kirfel J, Lieb V, Metzger E, Offermann A, Pantel K, Schuele R, Taubert H, Wach S, Perner S, Werner S, Aigner A. Sailer V, et al. Among authors: offermann a. Nat Rev Urol. 2023 Mar;20(3):158-178. doi: 10.1038/s41585-022-00677-z. Epub 2022 Nov 30. Nat Rev Urol. 2023. PMID: 36451039 Review.
62 results